bioRxivCell BiologyPreprint
Chronic Alcohol Exposure Induces Persistent DNA Damage Response Signaling and Sensitizes Breast Epithelial Cells to PARP Inhibition
Ming Zhao, Zhikun Ma, Amanda B. Parris, Jadyn Beacham, Xiaohe YangiD
Abstract
Chronic alcohol consumption is associated with increased breast cancer risk; however, the long-term effects of alcohol exposure on DNA damage response (DDR) signaling and therapeutic vulnerability in breast epithelial cells remain incompletely understood. In the present study, we established a chronic alcohol exposure model using immortalized human breast epithelial MCF-10A cells to investigate persistent alterations in DNA damage signaling and sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition. MCF-10A cells that chronically exposed to 0.2% alcohol for 20 weeks and then withdrew alcohol treatment for 4 weeks still retained elevated {gamma}H2AX levels and sustained activation of ATM/ATR-associated DDR pathways. Chronic alcohol-exposed cells also exhibited increased sensitivity to the PARP inhibitors olaparib and veliparib, as demonstrated by reduced cell viability, decreased clonogenic survival, and enhanced apoptosis. Mechanistically, olaparib induced greater G2/M checkpoint activation and replication-associated DNA damage in chronic alcohol-exposed cells compared with control cells. In addition, chronic alcohol exposure increased PARP expression and enhanced activation of DDR signaling following PARP inhibition. These findings demonstrate that chronic alcohol exposure induces persistent DNA repair stress and sensitizes breast epithelial cells to PARP inhibition. Our study suggests that chronic alcohol-associated genomic stress may create potential vulnerability to PARP inhibition.
- organism: human
- assay: DNA methylation
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination deficient cells
P. Verma, Y. Zhou, … R. A. Greenberg·bioRxiv·Dec 16, 2020
- Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer
N. A. Traphagen, G. N. Schwartz, … T. W. Miller·bioRxiv·Mar 16, 2023
- Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers
Lindsey N Aubuchon, Deanna H. Wong, … Priyanka Verma·bioRxiv·Mar 4, 2026
- Mammary lineage dictates homologous recombination repair and PARP inhibitor vulnerability
H. Kim, A. E. Casey, … R. Khokha·bioRxiv·May 14, 2021
- An inducible BRCA1 expression system with in vivo applicability uncovers activity of the combination of ATR and PARP inhibitors to overcome therapy resistance
Elsa Irving, Alaide Morcavallo, … Josep V. Forment·CancersPeer-reviewed·Jan 20, 2026
- Chromatin-Bound PARP1 Correlates with Upregulation of Inflammatory Genes in Response to Long-Term Treatment with Veliparib
I. Alvarado-Cruz, M. Mahmoud, … J. B. Sweasy·bioRxiv·Mar 8, 2020